Dr. Reddy's Laboratories reported a weak Q1 fiscal 2027 with earnings per share of $0.06, impacted by a ₹2.4 billion provision for defective semaglutide batches. This led to a 9.4% stock price drop. Pomerantz LLP is investigating whether the company and its executives engaged in securities fraud or other unlawful practices. Investors affected by the stock drop are encouraged to contact the law firm for potential class action participation.
Dr. Reddy's Laboratories Limited is the subject of an investor alert amid a legal investigation. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: out of 91 priced US health-sector stocks tradable on Pluang, 59 rose and 31 fell today. Notable movers include AbCellera Biologics Inc (ABCL) with a price of USD 12.38 and a 1-day change of +6.08%, Crispr Therapeutics AG (CRSP) at USD 55.17 with +5.67%, and Recursion Pharmaceuticals Inc (RXRX) at USD 3.37 with +5.64%.
Fluence Energy's stock price target was cut sharply from $15.00 to $4.00 by RBC Capital analyst Christopher Dendrinos after the company slashed its 2026 revenue forecast from $3.00 billion to $2.40 billion. The company now expects an adjusted EBITDA ...
Regency Centers reported solid Q2 2026 results with Funds From Operations (FFO) at $1.21 per share and a 3.8% growth in same-property Net Operating Income (NOI). The company raised its full-year guidance, signaling confidence in continued growth. Reg...
Ciena reported a 37% revenue increase to $1.67 billion and a 215% rise in adjusted EPS to $2.11 in its fiscal third quarter, driven by strong demand from AI and cloud infrastructure. The company is well positioned to benefit from the AI networking ma...
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
